{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:27:31Z","timestamp":1744806451083},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENH","award":["2390038"],"award-info":[{"award-number":["2390038"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.cca.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T05:00:11Z","timestamp":1478149211000},"page":"50-56","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study"],"prefix":"10.1016","volume":"464","author":[{"given":"Madoka","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuto","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Mizoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seisuke","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoriyasu","family":"Uju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Yasukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hisaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Kusanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuei","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.11.002_bb0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2016.11.002_bb0010","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijcard.2014.03.101","article-title":"Schizophrenia and risk of stroke: a meta-analysis of cohort studies","volume":"173","author":"Li","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2016.11.002_bb0015","article-title":"Increased silent brain infarction accompanied with high prevalence of diabetes and dyslipidemia in psychiatric inpatients: a cross-sectional study","volume":"17","author":"Kanzaki","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.cca.2016.11.002_bb0020","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1161\/01.STR.0000190004.36793.2d","article-title":"Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke","volume":"36","author":"Tomitori","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2016.11.002_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2010.03.031","article-title":"Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP","volume":"211","author":"Yoshida","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2016.11.002_bb0030","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.12336","article-title":"Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells","volume":"127","author":"Saiki","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2016.11.002_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group","volume":"340","author":"O'Leary","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.11.002_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jstrokecerebrovasdis.2006.08.001","article-title":"Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts","volume":"16","author":"Inoue","year":"2007","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.cca.2016.11.002_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.11.001","article-title":"Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study","volume":"15","author":"Bokura","year":"2006","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.cca.2016.11.002_bb0050","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1074\/jbc.273.26.16058","article-title":"Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins","volume":"273","author":"Uchida","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2016.11.002_bb0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.atherosclerosis.2008.07.022","article-title":"Acrolein, IL-6 and CRP as markers of silent brain infarction","volume":"203","author":"Yoshida","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2016.11.002_bb0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000104478","article-title":"Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA study). 1. Design and results at enrollment","volume":"24","author":"Shinohara","year":"2007","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.cca.2016.11.002_bb0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/clinchem\/43.10.1919","article-title":"Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis","volume":"43","author":"Ellenius","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.11.002_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2016.11.002_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.11.002_bb0080","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.STR.28.10.1932","article-title":"Subcortical silent brain infarction as a risk factor for clinical stroke","volume":"28","author":"Kobayashi","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2016.11.002_bb0085","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/archneur.60.10.1394","article-title":"Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2","volume":"60","author":"Lopez","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cca.2016.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.STR.0000068408.82115.D2","article-title":"Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study","volume":"34","author":"Vermeer","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2016.11.002_bb0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","article-title":"Silent brain infarcts: a systematic review","volume":"6","author":"Vermeer","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2016.11.002_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.309.6946.11","article-title":"Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study","volume":"309","author":"Lindenstrom","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2016.11.002_bb0105","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/HJH.0b013e328330e882","article-title":"Impact of blood pressure levels on different types of stroke: the Hisayama study","volume":"27","author":"Arima","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.11.002_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/STROKEAHA.109.564708","article-title":"Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study","volume":"41","author":"Doi","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2016.11.002_bb0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cca.2010.11.003","article-title":"Relationship between metabolic disorders and relative risk values of brain infarction estimated by protein-conjugated acrolein, IL-6 and CRP together with age","volume":"412","author":"Yoshida","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.11.002_bb0120","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1253\/circj.CJ-13-0786","article-title":"Epidemiology of stroke and coronary artery disease in Asia","volume":"77","author":"Hata","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2016.11.002_bb0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.schres.2012.10.041","article-title":"C-reactive protein is elevated in schizophrenia","volume":"143","author":"Dickerson","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.cca.2016.11.002_bb0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.schres.2014.09.015","article-title":"Elevated serum levels of TNF-\u03b1, IL-6 and IL-18 in chronic schizophrenic patients","volume":"159","author":"Luo","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.cca.2016.11.002_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharep.2014.09.007","article-title":"Therapeutic effect of aripiprazole in chronic schizophrenia is accompanied by anti-inflammatory activity","volume":"67","author":"Sobis","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cca.2016.11.002_bb0140","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1161\/STROKEAHA.109.553248","article-title":"Intense correlation between brain infarction and protein-conjugated acrolein","volume":"40","author":"Saiki","year":"2009","journal-title":"Stroke"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811630448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811630448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T23:18:03Z","timestamp":1601162283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811630448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":28,"alternative-id":["S000989811630448X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.11.002","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}